Citations

Institution: Mayo Clinic Clear

Showing 10 of 108081 citations.

Novel Targeted Agents and the Need to Refine Clinical End Points in Chronic Lymphocytic Leukemia
Cheson, Bruce D. , Byrd, John C., Rai, Kanti R., Flinn, Ian W. , Byrd, John C. , Rai, Kanti R., Kay, Neil E. , O’Brien, Susan , Wiestner, Adrian U. , Kipps, Thomas J. , Flinn, Ian W , Byrd, John C

Journal of Clinical Oncology | July 10, 2012 | Volume: 30 | Issue: 23 | Pages: 2820-2822

10.1200/jco.2012.43.3748 | PMID 22778323 Get It

LRP1-Dependent Endocytic Mechanism Governs the Signaling Output of the Bmp System in Endothelial Cells and in Angiogenesis
Pi, Xinchun , Schmitt, Christopher E., Xie, Liang, Portbury, Andrea L., Wu, Yaxu, Lockyer, Pamela , Moser, Martin , Bu, Guojun , Flynn, Edward J. , Jin, Suk-Won, Patterson, Cam, Dyer, Laura A. , Jin, Suk‐Won , Bu, Guojun

Circulation Research | July 10, 2012 | Volume: 111 | Issue: 5 | Pages: 564-574

10.1161/circresaha.112.274597 | PMID 22777006 Get It

Rationale: Among the extracellular modulators of Bmp (bone morphogenetic protein) signaling, Bmper (Bmp endothelial cell precursor-derived regulator) both enhances and inhibits Bmp signaling. Recently we found that Bmper modulates Bmp4 activity via a concentration-dependent, endocytic trap-and–sink mechanism. Objective: To investigate the molecular mechanisms required for endocytosis of the Bmper/Bmp4 and signaling complex and determine the mechanism of Bmper's differential effects on Bmp4 signaling. Methods and Results: Using an array of biochemical and cell biology techniques, we report that LRP1 (LDL receptor-related protein 1), a member of the LDL receptor family, acts as an endocytic receptor for Bmper and a coreceptor of Bmp4 to mediate the endocytosis of the Bmper/Bmp4 signaling complex. Furthermore, we demonstrate that LRP1-dependent Bmper/Bmp4 endocytosis is essential for Bmp4 signaling, as evidenced by the phenotype of lrp1-deficient zebrafish, which have abnormal cardiovascular development and decreased Smad1/5/8 activity in key vasculogenic structures. Conclusions: Together, these data reveal a novel role for LRP1 in the regulation of Bmp4 signaling by regulating receptor complex endocytosis. In addition, these data introduce LRP1 as a critical regulator of vascular development. These observations demonstrate Bmper's ability to fine-tune Bmp4 signaling at the single-cell level, unlike the spatial regulatory mechanisms applied by other Bmp modulators.
Multiple Papillary Fibroelastomas
Vittala, Satya S., Click, Roger L., Najib, Mohammad Q. , Khandheria, Bijoy K. , Edwards, William D. , Maleszewski, Joseph J. , Chaliki, Hari P. , Challa, Suresh

Circulation | July 9, 2012 | Volume: 126 | Issue: 2 | Pages: 242-243

10.1161/circulationaha.111.049569 | PMID 22777667 Get It

Outside Case Review of Surgical Pathology for Referred Patients: The Impact on Patient Care
Swapp, Ryan E., Aubry, Marie Christine, Salomão, Diva R. , Cheville, John C.

Archives of Pathology & Laboratory Medicine | July 9, 2012 | Volume: 137 | Issue: 2 | Pages: 233-240

10.5858/arpa.2012-0088-oa | PMID 22775269 Get It

Context.— Original surgical pathology materials from external sources are reviewed by our pathologists for referred patients before their clinical evaluation and treatment. Objective.— To identify the rate of major disagreements with diagnoses from external institutions and to characterize the nature and impact of discordant diagnoses on patient care. Design.— We identified and reviewed all surgical pathology cases, except for medical liver, medical renal, and cardiac pathology cases, for the period between January 1, 2005, and December 31, 2010, to determine the overall frequency of major disagreements, defined as any change in diagnosis having a substantial impact on patient management. Results.— Our review of 71 811 cases initially examined between 2005 and 2010 identified 457 major disagreements (0.6%). The most frequent areas of disagreement were gastrointestinal (80 cases; 17.5%), lymph node (73; 16.0%), bone/soft tissue (47; 10.3%), and genitourinary (43; 9.4%). For a subset of 166 cases reviewed between July 1, 2009, and December 31, 2010, follow-up data were available for 140 (84.3%). Treatment was affected by a changed diagnosis in 126 cases (90.0%), and prognosis was affected in 129 cases (92.1%). For 86 (51.8%) of the 166 cases, additional tissue was obtained. Revised diagnoses concurred with follow-up tissue diagnosis in 84.9% (73 cases), whereas they differed from follow-up tissue diagnosis in 15.1% (13 cases). Conclusions.— Our findings demonstrate the value of outside case review of pathology materials for referred patients, and suggest that it decreases the likelihood of diagnostic errors and provides better protection for patients.
Identification of single gene deletions at 15q13.3: further evidence that CHRNA7 causes the 15q13.3 microdeletion syndrome phenotype
Hoppman‐Chaney, Nicole L., Wain, KE, Seger, PR, Dw, Superneau, Hodge, J.C., Superneau, Duane W.

Clinical Genetics | July 9, 2012 | Volume: 83 | Issue: 4 | Pages: 345-351

10.1111/j.1399-0004.2012.01925.x | PMID 22775350 Get It

The 15q13.3 microdeletion syndrome (OMIM #612001) is characterized by a wide range of phenotypic features, including intellectual disability, seizures, autism, and psychiatric conditions. This deletion is inherited in approximately 75% of cases and has been found in mildly affected and normal parents, consistent with variable expressivity and incomplete penetrance. The common deletion is approximately 2 Mb and contains several genes; however, the gene(s) responsible for the resulting clinical features have not been clearly defined. Recently, four probands were reported with small deletions including only the CHRNA7 gene. These patients showed a wide range of phenotypic features similar to those associated with the larger 15q13.3 microdeletion. To further correlate genotype and phenotype, we queried our database of >15,000 patients tested in the Mayo Clinic Cytogenetics Laboratory from 2008 to 2011 and identified 19 individuals (10 probands and 9 family members) with isolated heterozygous CHRNA7 gene deletions. All but two infants displayed multiple features consistent with 15q13.3 microdeletion syndrome. We also identified the first de novo deletion confined to CHRNA7 as well as the second known case with homozygous deletion of CHRNA7 only. These results provide further evidence implicating CHRNA7 as the gene responsible for the clinical findings associated with 15q13.3 microdeletion.
An Underreported Consequence of Obesity in Pregnancy: Patient-Prosthesis Mismatch
Hartman, William R. , Rehfeldt, Kent H., Arendt, Katherine W.

Case Reports in Obstetrics and Gynecology | July 8, 2012 | Volume: 2012 | Issue: No issue available | Pages: 1-4

10.1155/2012/918352 | PMID 22830065 Get It

As the rate of obesity increases in childbearing-aged women, so too will the complications of obesity in pregnancy. An uncommon and likely underreported complication occurs in obese women who have received prepregnancy cardiac valve replacement with a prosthesis that is inadequately sized for body habitus, a condition referred to as patient-prosthesis mismatch (PPM). The physiologic changes of pregnancy as well as the increased weight gain combine to exacerbate PPM. We report a case of PPM that necessitated prosthesis replacement at 16-week gestation. As the incidence of this clinical scenario increases, it is important to understand the implications of prosthesis sizing, as well as the repercussions of having cardiopulmonary surgery to correct the undersized valve prosthesis while pregnant.
CD8 T Cell-Initiated Blood–Brain Barrier Disruption Is Independent of Neutrophil Support
Johnson, Holly L. , Jin, Fang, Hanson, Lisa , Gamez, Jeffrey D., Pirko, Istvan, Johnson, Aaron J. , Chen, Yi , Johnson, Aaron J.

The Journal of Immunology | July 7, 2012 | Volume: 189 | Issue: 4 | Pages: 1937-1945

10.4049/jimmunol.1200658 | PMID 22772449 Get It

Abstract Blood–brain barrier (BBB) disruption is a common feature of numerous neurologic disorders. A fundamental question in these diseases is the extent inflammatory immune cells contribute to CNS vascular permeability. We have previously shown that CD8 T cells play a critical role in initiating BBB disruption in the peptide-induced fatal syndrome model developed by our laboratory. However, myelomonocytic cells such as neutrophils have also been implicated in promoting CNS vascular permeability and functional deficit in murine models of neuroinflammatory disease. For this reason, we evaluated neutrophil depletion in a murine model of CD8 T cell-initiated BBB disruption by employing traditionally used anti-granulocyte receptor-1 mAb RB6-8C5 and Ly-6G–specific mAb 1A8. We report that CNS-infiltrating antiviral CD8 T cells express high levels of granulocyte receptor-1 protein and are depleted by treatment with RB6-8C5. Mice treated with RB6-8C5, but not 1A8, display: 1) intact BBB tight junction proteins; 2) reduced CNS vascular permeability visible by gadolinium-enhanced T1-weighted magnetic resonance imaging; and 3) preservation of motor function. These studies demonstrate that traditional methods of neutrophil depletion with RB6-8C5 are broadly immune ablating. Our data also provide evidence that CD8 T cells initiate disruption of BBB tight junction proteins and CNS vascular permeability in the absence of neutrophil support.
A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer
Bible, Keith C. , Menefee, Michael E., Smallridge, Robert C., Molina, Julian R. , Maples, William J., Karlin, Nina J. , Traynor, Anne M. , Kumar, Priya , Lim, Wan‐Teck , Bossou, Ayoko R., Isham, Crescent R., Webster, Kevin, Kukla, Andrea K., Bieber, Carolyn, Burton, Jill K., Harris, Pamela Jo , Erlichman, Charles , Suman, Vera J. , Goh, Boon Cher

The Journal of Clinical Endocrinology & Metabolism | July 7, 2012 | Volume: 97 | Issue: 9 | Pages: 3179-3184

10.1210/jc.2012-1520 | PMID 22774206 Get It

Recurrent dyspnea following multiple ablations for atrial fibrillation explained by the “stiff left atrial syndrome”
Witt, Chance M. , Powell, Brian D. , Holmes, David R. , Alli, Oluseun

Catheterization and Cardiovascular Interventions | July 6, 2012 | Volume: 82 | Issue: 5 | Pages: No page available

10.1002/ccd.24556 | PMID 22777844 Get It

We present the case of a patient who underwent repeated ablations for atrial fibrillation and presented with recurrent dyspnea, elevated left atrial pressure with large V waves in the absence of mitral regurgitation. This case provides an example of “stiff left atrial syndrome” as has been described in patients with mitral valve replacement and only recently in patients with radiofrequency ablations for atrial fibrillation. © 2012 Wiley Periodicals, Inc.
Biomechanical analysis of a novel hook-screw technique for C1–2 stabilization
Reis, Marco T., Nottmeier, Eric W. , Reyes, Phillip M., Baek, Seungwon , Crawford, Neil R.

Journal of Neurosurgery: Spine | July 6, 2012 | Volume: 17 | Issue: 3 | Pages: 220-226

10.3171/2012.5.spine1242 | PMID 22769729 Get It

The Food and Drug Administration has not cleared the following medical devices for the use described in this study. The following medical devices are being discussed for an off-label use: cervical lateral mass screws. Object As an alternative for cases in which the anatomy and spatial relationship between C-2 and a vertebral artery precludes insertion of C-2 pedicle/pars or C1–2 transarticular screws, a technique that includes opposing laminar hooks (claw) at C-2 combined with C-1 lateral mass screws may be used. The biomechanical stability of this alternate technique was compared with that of a standard screw-rod technique in vitro. Methods Flexibility tests were performed in 7 specimens (occiput to C-3) in the following 6 different conditions: 1) intact; 2) after creating instability and attaching a posterior cable/graft at C1–2; 3) after removing the graft and attaching a construct comprising C-1 lateral mass screws and C-2 laminar claws; 4) after reattaching the posterior cable-graft at C1–2 (posterior hardware still in place); 5) after removing the posterior cable-graft and laminar hooks and placing C-2 pedicle screws interconnected to C-1 lateral mass screws via rod; and 6) after reattaching the posterior cable-graft at C1–2 (screw-rod construct still in place). Results All types of stabilization significantly reduced the range of motion, lax zone, and stiff zone compared with the intact condition. There was no significant biomechanical difference in terms of range of motion or lax zone between the screw-rod construct and the screw-claw-rod construct in any direction of loading. Conclusions The screw-claw-rod technique restricts motion much like the standard Harms technique, making it an acceptable alternative technique when aberrant arterial anatomy precludes the placement of C-2 pars/pedicle screws or C1–2 transarticular screws.